Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ICA Aesthetic Navigation is a private German healthcare technology company operating in aesthetic medicine and consumer skin-health assessment through its CAARISMA brand. The company develops AI-driven facial analysis and skin assessment tools that provide personalized beauty and skincare guidance, objective aesthetic measurements, and connections to qualified physicians and experts. Its products appear centered on software-based facial analytics such as the Facial Aesthetic Index (FAI), Facial Youthfulness Index (FYI), and Skin Quality Index (SQI), rather than on therapeutic drug development. The business is positioned at the intersection of digital health, dermatology-adjacent aesthetics, and consumer beauty technology, with a commercial app and related intellectual property in computer-based body and facial analysis. Based on available public information, ICA Aesthetic Navigation is an operating private company headquartered in Frankfurt am Main, Germany.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ICA Aesthetic Navigation.